Category
The August 2026 Monthly FDA-483 Summary delivers an empirical audit breakdown of 142 inspection citations across 38 manufacturing facilities. Discover…
Discover key takeaways from August 2026 FDA inspection data. This briefing examines critical Form 483 citations across CAPA root cause…
An executive analysis of August 2026 Dietary Supplement FDA Inspection data, reviewing critical 21 CFR Part 111 cGMP violations across…
An executive analysis of August 2026 FDA enforcement and recalls data, breaking down Form 483 escalations, microbial contamination risks, particulate…
Discover what needs to happen within the mandatory 15-business-day window following an FDA Form 483 issuance. This comprehensive timeline guide…
Receiving an FDA Warning Letter represents an acute corporate event requiring immediate C-suite intervention. This executive roadmap outlines what senior…
Discover what an FDA mock inspection should include and determine the ideal operational timeline to schedule one. This comprehensive guide…
Are you truly ready for an unannounced FDA inspection? This comprehensive self-assessment provides quality leaders, CDMOs, and sponsors with 20…
Discover how federal investigators inspect high-purity pharmaceutical water systems under 21 CFR Part 211. This foundational playbook guide walks quality…
Discover what federal inspectors examine during an FDA HVAC inspection pharmaceutical audit. This comprehensive guide walks quality leaders, facility engineers,…
Sign in to access member resources, inspection tools and training.
New here? Create an account
Set up an account to access member resources, inspection tools and training.
Already have an account? Log in
Enter your username or email and we will send you a link to set a new password.
Remembered it? Log in
Book a 60-minute strategy session with a former FDA investigator and decide your next step with confidence.
Book Consultation
